Header Logo
Last Name

You can now add alternative names! Click here to add other names that you've published under.


Search Results to Shmuel Yaccoby

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Yaccoby, Shmuel

Item TypeName
Academic Article Heparanase promotes the spontaneous metastasis of myeloma cells to bone.
Academic Article Consequences of interactions between the bone marrow stroma and myeloma.
Academic Article Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.
Academic Article Establishment and exploitation of hyperdiploid and non-hyperdiploid human myeloma cell lines.
Academic Article The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
Academic Article Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma.
Academic Article Fibroblast activation protein (FAP) is upregulated in myelomatous bone and supports myeloma cell survival.
Academic Article Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.
Academic Article Human placenta-derived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone.
Academic Article Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo.
Academic Article Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.
Academic Article The molecular classification of multiple myeloma.
Academic Article Highly activated and expanded natural killer cells for multiple myeloma immunotherapy.
Academic Article Role of decorin in the antimyeloma effects of osteoblasts.
Academic Article Atacicept (TACI-Ig) inhibits growth of TACI(high) primary myeloma cells in SCID-hu mice and in coculture with osteoclasts.
Academic Article The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells.
Academic Article Soluble syndecan-1 promotes growth of myeloma tumors in vivo.
Academic Article Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth.
Academic Article Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myeloma.
Academic Article Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple myeloma.
Academic Article Inhibitor of DASH proteases affects expression of adhesion molecules in osteoclasts and reduces myeloma growth and bone disease.
Academic Article The proliferative potential of myeloma plasma cells manifest in the SCID-hu host.
Academic Article The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.
Academic Article The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
Academic Article The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth.
Academic Article Cancer and the microenvironment: myeloma-osteoclast interactions as a model.
Academic Article Repression of multiple myeloma growth and preservation of bone with combined radiotherapy and anti-angiogenic agent.
Academic Article Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins.
Academic Article Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.
Academic Article NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity.
Academic Article Primary myeloma cells growing in SCID-hu mice: a model for studying the biology and treatment of myeloma and its manifestations.
Academic Article Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.
Academic Article Fenretinide inhibits myeloma cell growth, osteoclastogenesis and osteoclast viability.
Academic Article Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma.
Concept Antibody-Dependent Cell Cytotoxicity
Concept Cell Communication
Concept Cell Cycle
Concept Cell Movement
Concept Cell Membrane
Concept Cell Division
Concept Clone Cells
Concept Cell Adhesion
Concept Cells, Cultured
Concept Cell Differentiation
Concept Epithelial Cells
Concept Bone Marrow Cells
Concept Hematopoietic Stem Cells
Concept Hematopoietic Stem Cell Transplantation
Concept Cell Line
Concept Cell Survival
Concept Cell Adhesion Molecules
Concept Cell Proliferation
Concept Stromal Cells
Concept Leukemia, Lymphocytic, Chronic, B-Cell
Concept B-Cell Activating Factor
Concept Plasma Cells
Concept Mesenchymal Stem Cell Transplantation
Concept Endothelial Cells
Concept Cell Line, Tumor
Concept Cell Polarity
Concept Killer Cells, Natural
Concept Stem Cells
Concept Leukemia, Plasma Cell
Concept Tumor Cells, Cultured
Concept Neoplastic Stem Cells
Concept Cell Transplantation
Concept NK Cell Lectin-Like Receptor Subfamily K
Academic Article Activation of mitogen-activated protein kinase through alpha5/beta1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cells
Academic Article Role of Bruton's tyrosine kinase (BTK) in growth and metastasis of INA6 myeloma cells.
Academic Article Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.
Academic Article CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.
Academic Article Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.
Academic Article A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.
Academic Article Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow.
Academic Article A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition.
Academic Article Two States of Myeloma Stem Cells.
Academic Article The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma.
Academic Article Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.
Grant Potentiating Natural Killer Cell Anti-Myeloma Effects
Grant Myeloma-Microenvironment Interaction Dynamics
Grant Effect of antiCD56-cytotoxic drug conjugate on myeloma cell growth in the bone marrow microenvironment ex vivo and in vivo
Grant Effect of BI-505 ICAM-1 antibody on growth of myeloma cells in vitro and in vivo
Academic Article PHF19 inhibition as a therapeutic target in multiple myeloma.
Grant Effect of BI-505 ICAM-1 antibody on growth of myeloma cells in vitro and in vivo
Academic Article Growth and dormancy control of myeloma cells by mesenchymal stem cells.
Academic Article EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression.

Search Criteria
  • Cells